Dr Mark S Soloway was born on in 1943 and is an American professor emeritus of urology, known for his contributions to prostate, bladder and kidney cancer research.
12 Facts About Mark Soloway
Mark Soloway served as a professor and chairman of the Department of Urology at the University of Miami Miller School of Medicine and later as the chief of urologic oncology at Memorial Hospital in Hollywood, Florida.
Mark Soloway subsequently returned to Case Western Reserve to complete his residency in urology.
In 1968 Mark Soloway began a two-year clinical fellowship at the National Cancer Institute of the National Institute of Health in Bethesda, Maryland, where his contributions to the field of urology began.
Mark Soloway's research included some early studies on combining chemo and radiation.
From 1991 to 2010 Mark Soloway was professor and chairman of the University of Miami Miller School of Medicine Department of Urology.
Mark Soloway was one of the first urologic oncologists to use flexible cystoscopy as an integral part of his office practice; today, most of the world uses it.
Mark Soloway has made important contributions to prostate cancer research, building on his earlier work in bladder cancer.
Mark Soloway's work has helped improve several key areas of prostate cancer care:.
Mark Soloway promoted the TRUS biopsy method to urologists for their outpatient clinics.
Mark Soloway has worked closely in tandem with a former resident and co-faculty member, Gaetano Ciancio on kidney cancer.
Mark Soloway developed one of the first prostate cancer support groups in Memphis, Tennessee.